Seed Round - Modifi Bio

Seed Round - Modifi Bio

Investment Firm

Overview

Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.

Announced Date

Oct 16, 2023

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

BrightEdge Fund

BrightEdge Fund

BrightEdge Fund is a early_stage_venture firm.

Participant Investors

7

Investor Name
Participant InvestorNational Brain Tumor Society
Participant InvestorBrightEdge Fund
Participant InvestorHighCape Partners
Participant InvestorIronwood Capital
Participant InvestorConnecticut Innovations

Round Details and Background

Modifi Bio raised $4300000 on 2023-10-16 in Seed Round

Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 25, 2022
Grant - Modifi Bio
1-2.4M
Jul 28, 2022
Seed Round - Modifi Bio
5-6.4M
Oct 16, 2023
Seed Round - Modifi Bio
7-4.3M

Recent Activity

There is no recent news or activity for this profile.